Acadia Healthcare Company Inc (ACHC)
Days of sales outstanding (DSO)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, it appears that the days of sales outstanding (DSO) ratio for Acadia Healthcare Company Inc is not available for any of the specified dates from March 31, 2020, to December 31, 2024.
The DSO ratio is a measure of how long it takes a company to collect its accounts receivable, indicating the efficiency of its credit and collection policies. A lower DSO is generally preferable as it signifies faster collection of receivables, better liquidity, and potentially fewer bad debts.
In this case, the lack of specific data on DSO over the given period makes it challenging to assess Acadia Healthcare's effectiveness in managing its accounts receivable. It would be beneficial to have access to the actual DSO figures to conduct a more in-depth analysis of the company's working capital management and overall financial performance.
Peer comparison
Dec 31, 2024